BCM
KNTE

Bridgeway Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bridgeway Capital Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-91,300
Closed -$216K – 1392
2023
Q4 		$216K Sell
91,300
-53,000
-37% -$126K ﹤0.01% 1122
2023
Q3 		$202K Buy
+144,300
New +$202K ﹤0.01% 1098